This morning, an article popped up on my computer suggesting that the high-dose flu vaccine—the one recommended for seniors—may have properties that help protect against Alzheimer’s disease.

Now, that certainly caught my attention! It sounded interesting and worthy of a little investigative work. And I suspect my phone will soon start ringing with friends asking whether they should get the flu shot to help prevent Alzheimer’s.

Who knows? Perhaps the news will encourage some seniors who have been hesitant about getting their annual flu shot to be first in line at the pharmacy tomorrow!

But before we get too excited, let’s put on our investigative hats and separate scientific evidence from wishful thinking.

Is this fact or fiction?

The answer is somewhere in between. There is legitimate scientific research suggesting that flu vaccination may be associated with a reduced risk of Alzheimer’s disease. However, saying that a high-dose flu shot prevents Alzheimer’s goes beyond what the evidence currently establishes.

As a microbiologist, I appreciate the distinction. An encouraging research finding is not the same as proof of cause and effect. We need to examine what the researchers actually discovered before jumping to conclusions.

So, let’s look at the science.

What did the 2026 study find?

A study published in Neurology on April 28, 2026, examined the relationship between high-dose and standard-dose flu vaccination and the risk of Alzheimer’s disease in adults aged 65 and older.

Researchers analyzed health insurance claims involving more than 164,000 people and followed outcomes over a period extending to three years.

Here are the important findings:

• An encouraging association: People who received the high-dose flu vaccine had a lower observed risk of developing Alzheimer’s disease than those who received the standard-dose vaccine.
• An important limitation: The study was based on a retrospective analysis of health insurance data. It was not a randomized clinical trial designed to establish that the high-dose vaccine prevents Alzheimer’s disease.
• An unanswered question: Researchers do not yet know precisely why this association was observed. Could it involve fewer influenza infections, changes in inflammation, other immune-system effects, or differences between the people receiving the two vaccines? Further research is needed.

The findings are intriguing, but they do not establish that the high-dose vaccine was responsible for the lower observed risk.

Why might a flu vaccine affect Alzheimer’s risk?

Researchers have several hypotheses worth investigating.

1. Inflammation

Influenza infection can trigger a substantial inflammatory response. Scientists are investigating whether preventing infections might reduce processes that contribute to neurological injury or cognitive decline.

2. Immune-system effects

Vaccination stimulates the immune system. Researchers are exploring whether these immune responses might influence biological processes involved in neurodegenerative diseases.

3. Preventing serious illness

Severe infections can place considerable stress on the body, particularly in older adults. Preventing influenza and its complications may help preserve overall health.

These are plausible explanations, not established mechanisms. We should not confuse a scientific hypothesis with a proven explanation.

Does other research support these findings?

Yes, there is additional research worth watching, although the results are not entirely consistent.

A 2025 systematic review and meta-analysis examined eight studies involving nearly 10 million people. It found that influenza vaccination was associated with a lower risk of developing dementia in certain high-risk populations. However, the association was not statistically significant across the overall population.

Importantly, dementia and Alzheimer’s disease are not interchangeable terms. Alzheimer’s is one type of dementia, and a finding involving dementia generally does not automatically establish a protective effect against Alzheimer’s specifically.

Taken together, these findings provide a reason for further investigation, not a basis for declaring that we have discovered a new way to prevent Alzheimer’s disease.

Should seniors get the high-dose flu shot?

Yes, for its established protection against influenza—not because it has been proven to prevent Alzheimer’s disease.

The CDC preferentially recommends one of three flu vaccines for adults aged 65 and older: the high-dose vaccine, the recombinant vaccine, or the adjuvanted vaccine.

These vaccines are recommended because of their benefits against influenza in older adults. The Alzheimer’s research is an additional area of scientific interest, not an established reason for choosing a particular flu vaccine.

If you are unsure which vaccine is appropriate for you, consult your healthcare professional.

My scientific verdict

FACT: A 2026 study found an association between receiving the high-dose flu vaccine and a lower observed risk of Alzheimer’s disease compared with receiving the standard-dose vaccine.

NOT YET PROVEN: That the high-dose flu vaccine actually prevents Alzheimer’s disease or should be administered specifically for that purpose.

MY CONCLUSION: This is promising research, not fiction. But promising research is not proof.

As a microbiologist, I have spent much of my professional life examining scientific evidence and explaining it to students and the public. One of the most important lessons in science is that we must distinguish between what we know, what we suspect, and what we have yet to prove.

Medical headlines often turn a preliminary finding into what sounds like a scientific breakthrough. The public reads the headline, remembers the claim, and may never discover the qualifications buried in the article.

That is why we must be cautious when reading about a potential medical discovery. We should welcome encouraging research, but we must also ask the right questions: How was the study conducted? What did the researchers actually measure? Were other explanations considered? And have the findings been confirmed by additional studies?

I would love to see research eventually establish that flu vaccination offers some protection against Alzheimer’s disease. That would be wonderful news for seniors and their families.

But until the evidence is stronger, let’s not get ahead of the science.

Remember: Promising research is not proof. And when it comes to our health, the difference matters.

Michael Kossove is professor emeritus and an adjunct professor of microbiology at Tuoro University. He lives part time in Sullivan County, NY.